IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 149-156

  Koczorowska, Maria Magdalena ^a   Kwasniewska, Anna ^b   Gozdzicka Jozefiak, Anna ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cervical cancer; Human papillomavirus; Insulin like growth factor 1; Splicing

Indexed keywords

MESSENGER RNA; PROTEIN FOX 2; PROTEIN P1; PROTEIN P2; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRECANCER; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; UTERINE CERVIX CANCER; WART VIRUS;

EID: 78751615551     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.174     Document Type: Article

References (41)

1. Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 110: 525-541, 2006.
2. Madkan VK, Cook-Norris RH, Steadman MC, Arora A, Mendoza N and Tyring SK: The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors. Br J Dermatol 157: 228-241, 2007.
3. Samani AA, Yakar S, LeRoith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47, 2007.
4. Cohen P: Overview of the IGF-Isystem. Horm Res 65 (Suppl 1): 3-8, 2006.
5. Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8: 915-928, 2008.
6. Mittanck DW, Kim SW and Rotwein P: Essential promoter elements are located within the 5' untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126: 153-163, 1997.
7. Wierstra I: Sp1: emerging roles - beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun 372: 1-13, 2008.
8. LeRoith D and Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137, 2003.
9. Musarò A, Dobrowolny G and Rosenthal N: The neuroprotective effects of a locally acting IGF-1 isoform. Exp Gerontol 42: 76-80, 2007.
10. Gee SL, Aoyagi K, Lersch R, Hou V, Wu M and Conboy JG: Alternative splicing of protein 4.1Rexon 16: ordered excision of flanking introns ensures proper splice site choice. Blood 95: 692-699, 2000.
11. Baraniak AP, Chen JR and Garcia-Blanco A: Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol 26: 1209-1222, 2006.
12. Zhang C, Zhang Z, Castle J, Sun S, Jahnson J, Krainer AR and Zhang MQ: Defining the regulatory network of the tissue-specific splicing factors FOX-1 and FOX-2. Genes Dev 22: 2550-2563, 2008.
13. Jozefiak A, Pacholska-Bogalska J, Myga-Nowak M, Kedzia W, Kwasniewska A, Luczak M, Kedzia H and Gozdzicka-JozefiakA: Serum and tissue levels of insulin-like growth factor-I in women with dysplasia and HPV-positive cervical cancer. Mol Med Rep 1: 231-237, 2008.
14. Serrano ML, Sánchez-Gómez M and Bravo MM: Insulin-like growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer. Growth Horm IGF Res 17: 492-499, 2007.
15. Tan DS, Cook A and Chew SL: Nucleolar localization of an isoform of the IGF-I precursor. BMC Cell Biol 3: 17, 2002.
16. Tavassoli FA and Deville P: World Health Organization Classification of Tumors. Pathology, Genetics. Tumours of the Breast and Female Genital Organs. IRAC Press, Lyon, 2003.
17. Kosary CL: FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10: 31-46, 1994.
18. Manos MM, Ting Y, Wright DK, Lewis AI, Broker TR and Wolinsky SM: The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214, 1989.
19. Daud II and Scott ME: Validation of reference genes in cervical cell samples from human papillomavirus-infected and -uninfected women for quantitative reverse transcription-PCR assays. Clin Vaccine Immunol 15: 1369-1373, 2008.
20. Philippou A, Papageorgiou E, Bogdanis G, Halapas A, SourlaA, Maridaki M, Pissimissis N and Koutsilieris M: Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo 23: 567-575, 2009.
21. Matheny RW, Nindl BC and Adamo MI: Mechano-growth factor: a putative product of IGF 1 gene expression involved in tissue repair and regeneration. Endocrinology 151: 3865-3875, 2010.
22. Barton ER: The ABC of IGF 1 isoforms: impact on muscle hypertrophy and implication for repair. Appl Physiol Nutr Metab 31: 791-797, 2006.
23. Górecki DC, Beresewicz M and Zabłocka B: Neuroprotective effects of short peptides derived from the insulin-like growth factor 1. Neurochem Int 51: 451-458, 2007.
24. Vinciquerra M, Santini MP, Claycomb WC, Ladurner AG and Rosenthal N: Local-IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via Sirt1 activity. Aging (Albany NY): 43-62, 2010.
25. Ohtsuki T, Otsuki M, Murakami Y, Maekowa T, YamamotoT, Kasaka K, Takenchi S and Takahashi S: Organ-specific and age-dependent expression of insulin-like growth factor-I (IGF-I) mRNAvariants: IGF-IA and IB mRNAs in the mouse. Zoolog Sci 22: 1011-1021, 2005.
26. Pfeffer LA, Brisson BK, Lei H and Barton ER: The insulin-like growth factor (IGF)-IE-peptides modulate cell entry of the mature IGF-I protein. Mol Biol Cell 20: 3810-3817, 2009.
27. Bell I, Martin A and Roberts S: The E1 E4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. J Virol 81: 5437-5448, 2007.
28. Bodaghi S, Jia R and Zheng ZM: Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites. Virology 386: 32-43, 2009.
29. Cheunim T, Zhang J, Milligan SG, McPhillips MG and GrahamSV: The alternative splicing factor hnRNPA1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res 131: 189-198, 2008.
30. Mole S, McFarlane M, Chuen-Im T, Milligan SG, Millan D and Graham SV: RNAsplicing factors regulated by HPV16 during cervical tumour progression. J Pathol 219: 383-391, 2009.
31. Venables JP, Klinck R, Koh C, et al: Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16: 670-676, 2009.
32. Li T, Chen YH, Liu TJ, Jia J, Hampson S, Shan YX, Kibler D and Wang PH: Using DNAmicroarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells. Circ Res 93: 1202-1209, 2003.
33. Gloss B and Bernard HU: The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol 64: 5577-5584, 1990.
34. McPhillips MG, Veerapraditsin T, Cumming SA, Karali D, Milligan SG, Boner W, Morgan IM and Graham SV: SF2/ASF binds the human papillomavirus type 16 late RNAcontrol element and is regulated during differentiation of virus-infected epithelial cells. J Virol 78: 10598-10605, 2004.
35. Li B, Wang X, Zhou F, Saunders NA, Frazer IH and Zhao KN: Up-regulated expression of Sp1 protein coincident with a viral protein in human and mouse differentiating keratinocytes may act as a cell differentiation marker. Differentiation 76: 1068-1080, 2008.
36. Carboni JM, Lee AV, Hadsell DL, et al: Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65: 3781-3787, 2005.
37. Linnerth NM, Siwicky MD, Campbell CI, Watson KL, PetrikJJ, Whitsett JA and Moorehead RA: Type I insulin-like growth factor receptor induces pulmonary tumorigenesis. Neoplasia 11: 672-682, 2009.
38. Chong YM, Colston K, Jiang WG, Sharma AK and Mokbel K: The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue. Breast Cancer Res Treat 99: 275-288, 2006.
39. Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D and Baretton GB: Overexpression of the insulin-like growth factorI receptor in human colon carcinomas. Cancer 95: 2086-2095, 2002.
40. Werner H, Shalita-Chesner M, Abramovitch S, IdelmanG, Shaharabani-Gargir L and Glaser T: Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab 71: 315-320, 2000.
41. Kuramoto H, Hongo A, Liu Y, Ojima Y, Nahamura K, Seki N, Kodama J and Hiramatsu Y: Immunohistochemical evaluation of insulin-like growth factor 1, receptor status in cervical cancer specimens. Acta Medica Okayama 62: 251-259, 2008.